Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rescue Biomedical is a medical technology company developing an automated, closed-loop drug delivery system designed to prevent fatal opioid overdoses. The company's core technology consists of a wearable or implantable device that monitors physiological signals, such as blood oxygen levels and respiration, to detect signs of an overdose. Upon detection, the device automatically administers a life-saving dose of naloxone, bypassing the need for a bystander to intervene. Founded by researchers from Purdue University, the company aims to provide a safety net for individuals at high risk of opioid-induced respiratory depression. The system is designed to be particularly effective for those who use opioids alone, a high-risk scenario where traditional naloxone administration is impossible.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rescue Biomedical.